Biofrontera Stock Technical Analysis
| BFRI Stock | USD 0.78 0 0.17% |
As of the 16th of February 2026, Biofrontera shows the Standard Deviation of 6.09, mean deviation of 3.44, and Risk Adjusted Performance of (0.03). Biofrontera technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biofrontera Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biofrontera, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiofronteraBiofrontera | Build AI portfolio with Biofrontera Stock |
Biofrontera Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 6.0 | Strong Buy | 2 | Odds |
Most Biofrontera analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biofrontera stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biofrontera, talking to its executives and customers, or listening to Biofrontera conference calls.
Is there potential for Biotechnology market expansion? Will Biofrontera introduce new products? Factors like these will boost the valuation of Biofrontera. Projected growth potential of Biofrontera fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.50) | Revenue Per Share | Quarterly Revenue Growth (0.23) | Return On Assets | Return On Equity |
Understanding Biofrontera requires distinguishing between market price and book value, where the latter reflects Biofrontera's accounting equity. The concept of intrinsic value - what Biofrontera's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Biofrontera's price substantially above or below its fundamental value.
It's important to distinguish between Biofrontera's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biofrontera should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biofrontera's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Biofrontera 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biofrontera's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biofrontera.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Biofrontera on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Biofrontera or generate 0.0% return on investment in Biofrontera over 90 days. Biofrontera is related to or competes with Gelteq Limited, ProPhase Labs, Aytu BioScience, Evogene, Dogwood Therapeutics, Sensei Biotherapeutics, and Trinity Biotech. Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treat... More
Biofrontera Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biofrontera's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biofrontera upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 34.13 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 6.76 |
Biofrontera Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biofrontera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biofrontera's standard deviation. In reality, there are many statistical measures that can use Biofrontera historical prices to predict the future Biofrontera's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.11) |
Biofrontera February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 3.44 | |||
| Coefficient Of Variation | (2,341) | |||
| Standard Deviation | 6.09 | |||
| Variance | 37.03 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 34.13 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 6.76 | |||
| Skewness | 1.57 | |||
| Kurtosis | 9.67 |
Biofrontera Backtested Returns
Biofrontera is dangerous at the moment. Biofrontera secures Sharpe Ratio (or Efficiency) of 0.0144, which signifies that the company had a 0.0144 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Biofrontera, which you can use to evaluate the volatility of the firm. Please confirm Biofrontera's Risk Adjusted Performance of (0.03), standard deviation of 6.09, and Mean Deviation of 3.44 to double-check if the risk estimate we provide is consistent with the expected return of 0.0869%. Biofrontera has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 2.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biofrontera will likely underperform. Biofrontera right now shows a risk of 6.02%. Please confirm Biofrontera value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Biofrontera will be following its price patterns.
Auto-correlation | 0.39 |
Below average predictability
Biofrontera has below average predictability. Overlapping area represents the amount of predictability between Biofrontera time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biofrontera price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Biofrontera price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Biofrontera technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biofrontera Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biofrontera volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Biofrontera Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biofrontera on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biofrontera based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biofrontera price pattern first instead of the macroeconomic environment surrounding Biofrontera. By analyzing Biofrontera's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biofrontera's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biofrontera specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 1.96 | 10.03 | 9.02 | 6.78 | Days Of Inventory On Hand | 228.24 | 130.37 | 149.93 | 229.6 |
Biofrontera February 16, 2026 Technical Indicators
Most technical analysis of Biofrontera help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biofrontera from various momentum indicators to cycle indicators. When you analyze Biofrontera charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 3.44 | |||
| Coefficient Of Variation | (2,341) | |||
| Standard Deviation | 6.09 | |||
| Variance | 37.03 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 34.13 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 6.76 | |||
| Skewness | 1.57 | |||
| Kurtosis | 9.67 |
Biofrontera February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biofrontera stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | (0.07) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 0.78 | ||
| Day Typical Price | 0.78 | ||
| Price Action Indicator | 0.00 | ||
| Market Facilitation Index | 0.02 |
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |